Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: A multi-centre randomised trial

Archives of Disease in Childhood

Volumn 95, Issue 5, 2010, Pages 382-386

  Darke, Katrina ^a   Edwards, Stuart W ^a,b   Hancock, Eleanor ^b,c   Johnson, Anthony L ^d,e   Kennedy, Colin R ^f   Lux, Andrew L ^b,g   Newton, Richard W ^h   O'Callaghan, Finbar J K ^a,b,g,i   Verity, Christopher M ^j   Osborne, John P ^a,b  

^a ROYAL UNITED HOSPITALS BATH NHS FOUNDATION TRUST   (United Kingdom)

^b University of Bath   (United Kingdom)

^c Child and Family Health Services   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e MRC CLINICAL TRIALS UNIT   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^h ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

^j ADDENBROOKE S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; VIGABATRIN;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EPILEPSY; FOLLOW UP; GROUPS BY AGE; HORMONAL THERAPY; HUMAN; INFANT; INFANTILE SPASM; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SINGLE BLIND PROCEDURE; TELECONSULTATION; TREATMENT OUTCOME; VINELAND ADAPTIVE BEHAVIOR SCALE;

ANTICONVULSANTS; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COSYNTROPIN; EPIDEMIOLOGIC METHODS; GLUCOCORTICOIDS; HUMANS; INFANT; PREDNISOLONE; SEVERITY OF ILLNESS INDEX; SPASMS, INFANTILE; TREATMENT OUTCOME; VIGABATRIN;

EID: 77953741161     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.160606     Document Type: Article

References (14)

1. Dulac O, Chiron C, Robain O, et al. Infantile spasms: a pathophysiological hypothesis. Semin Pediatr Neurol 1994;1:83-9.
2. Storey TW, Rho JM, White SS, et al. Age-dependent differences in flurothyl-induced c-fos and c-jun mRNA expression in the mouse brain. Dev Neurosci 2002;24:294-9.
3. Koo B, Hwang PA, Logan WJ. Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups. Neurology 1993;43:2322-7. (Pubitemid 23346969)
4. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-8. (Pubitemid 39488062)
5. Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev 2008;4:CD001770.
6. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005;4:712-17. (Pubitemid 41457286)
7. Sparrow SS, Cicchetti DV. The behavior inventory for rating development (BIRD): assessments of reliability and factorial validity. Appl Res Ment Retard 1984;5:219-31.
8. Kennedy CR, Ayers S, Campbell MJ, et al. Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilation in infancy: follow-up at 1 year. Pediatrics 2001;108:597-607. (Pubitemid 32786586)
9. Asarnow RF, LoPresti C, Guthrie D, et al. Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms. Dev Med Child Neurol 1997;39:430-40. (Pubitemid 27338552)
10. Altman DG, Decks JJ, Clarke M, et al. The quality of systematic reviews. High quality reporting of both randomised trials and systematic reviews should be priority. BMJ 2000;321:297; author reply 298-9.
11. Humphrey A, Neville BG, Clarke A, et al. Autistic regression associated with seizure onset in an infant with tuberous sclerosis. Dev Med Child Neurol 2006;48:609-11. (Pubitemid 43919070)
12. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 1996;37:367-72. (Pubitemid 26100830)
13. Wild JM, Martinez C, Reinshagen G, et al. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 1999;40:1784-94.
14. Gaily E, Jonsson G, Lappi M. Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia 2009;50:206-16.